Fox News
Expand
Browse All Video
Watch Live

You're watching...

Organ transplant rejection a thing of the past?

Details

  • Description

    Dr. David Samadi explains findings of new study

  • Duration 4:18
  • Date

Clips

Also in this playlist...

Latest News

Auto-advance: ON

Auto-advance
View All

Transcript

This transcript is automatically generated

Yeah.

Yeah.

You can only imagine the challenge for -- patient who needs an organ transplant then gets the organ.

But faces a lifetime of drugs just to avoid rejection can be expensive and it doesn't always work.

Well now as a possible breakthrough in doctor David some money from New York's mount Sinai medical staff member of the Fox News medical -- team.

Is joining us now to talk about it those drugs can be very difficult to take right doctor.

Right Jamie but in general this is a very long journey for most people that get this kind of transplant the truth is they have to be on these anti rejection medications.

And as you mentioned are -- it costs about 20000 dollars a year.

It's also this side effects of this is really challenging.

They get multiple infections.

Risk of getting another cancer and long term there's heart disease and also high blood pressure and diabetes.

Imagine a world where they would get the transparent without being on all of these many cases and now there's a new clinical trial.

Out of that is in the hospital in Chicago Northwestern Memorial Hospital.

A university of Louisville, Kentucky.

Where there actually be using this stem cell.

A long.

Their transplant itself so we have some diagrams -- we can show you where they would these patients actually go through some chemotherapy and radiation to really suppress.

The immune system and then we would take to keep -- from the donor don't put in the recipient.

-- that stage we will also give a new set of stem cell from the donor so now we're treating -- new immune system where.

The recipient is going to have almost two immune system from the donor and his or her own.

That hybrid immune system is something called there's a new name for it which is called.

-- -- -- And what that does is that now the -- being recognized.

As -- own kidney not as a foreign once so the risk of rejection is going to be really reduce this is really.

And medical miracle.

It's only be done in about eight patients in a clinical trial.

Fortunately five out of these eight have been able to receive this without any issues and are not on any other medication which is a great news -- rejection.

And that they should end up having another transplant and the other two are still on medication so.

That statistic is statistically significant it it it is and we believe this starting to be true will patients being treated this way.

Soon.

Well obviously this is a small clinical trial so we need help much bigger.

Clinical trial to really.

Find out what's going on.

We also can extend this too long and heart and liver so the future of this is really bright.

I think this has opened up a whole new -- engineering field that we were not familiar with.

And you're combining transplant.

And stem cell -- either way you're tricking the immune system so it doesn't recognize the new organ as a foreign organ that's a big deal.

We know about taking a kidney or lung from a patient transplanting -- to another where do you take the stem cells from from that patient.

And when you hear stem cells sometimes people think controversy -- are these stem cells as controversial as that other studies and science we've been talking it.

-- question this is not dissent so that we talked about almost a month ago there are taking their blood actually be from the donor and they would clean up.

All of the extra.

That antibodies and they would get the real stem -- and injected to the patient.

So this is a real deal this is not some of those stories about stem cells where it's not you know -- this is effective.

And anyway the combination of stem cell.

And suppressing your -- system.

Would except that organ that's increases so as a -- boasts a total.

Doubled down that's -- interview -- -- very exciting long way to go but if you this is a great news for a lot of people.

Up for transpire in the future if this worked really well it would save a lot of money it would really saved the great quality of life for the patient and are going to get transplant.

And expanding this to liver heart along is a phenomenal indeed what.

Another thing you could expand the amount of organs available because of less rejection less need for the drugs bring the cost down like I think he's somebody who welcome you to a Sunday house -- -- -- -- tomorrow -- -- 30 AM April company related.

Gotta love it medical miracle -- -- times.

Load More